Subject category:
Finance, Accounting and Control
Published by:
Harvard Business Publishing
Version: 25 March 2003
Length: 6 pages
Data source: Field research
Abstract
This explores the valuation of an opportunity to license a compound before it enters clinical trials. Describes Merck's decision tree evaluation process is presented. Information required to evaluate a specific licensing opportunity is provided, including the costs of the three phases of the review process, the revenues if approved, and the probability of various outcomes. It includes an introduction to decision tree analysis and valuation.
Subject category:
Finance, Accounting and Control
Published by:
Harvard Business Publishing
Version: 9 October 2001
Length: 10 pages
Spanish language
Subject category:
Finance, Accounting and Control
Published by:
Harvard Business Publishing
Version: 25 March 2003
Length: 7 pages
Data source: Field research
About
Abstract
This explores the valuation of an opportunity to license a compound before it enters clinical trials. Describes Merck's decision tree evaluation process is presented. Information required to evaluate a specific licensing opportunity is provided, including the costs of the three phases of the review process, the revenues if approved, and the probability of various outcomes. It includes an introduction to decision tree analysis and valuation.
Settings
Related
Subject category:
Finance, Accounting and Control
Published by:
Harvard Business Publishing
Version: 9 October 2001
Length: 10 pages
Subject category:
Finance, Accounting and Control
Published by:
Harvard Business Publishing
Version: 25 March 2003
Length: 7 pages
Data source: Field research